ZimVie Announces Launch of Two Next-Generation Dental Solutions in the United States WESTMINSTER, Colo., June 16, 2022 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced the joint launch of the new,...

ZimVie Reports First Quarter 2022 Financial Results Third party net sales of $234.7 million, inclusive of $120.6 million in dental net sales and $114.1 million in spine net salesNet loss of ($25.7) million; net loss as a percentage of net sales of...

ZimVie to Report First Quarter 2022 Financial Results on May 5, 2022 WESTMINSTER, Colo., April 12, 2022 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, announced it will report financial results for the...

ZimVie Reports 2021 Financial Results, Reaffirms 2022 Financial Guidance, and Provides Supplemental Financial Information 2021 third party revenue of $1.009 billion, inclusive of $469 million in dental revenue and $540 million in spine revenueCompleted spine brand rationalization in the second half of 2021, resulting in...

ZimVie Completes Separation from Zimmer Biomet; Announces Board of Directors WESTMINSTER, Colo., March 01, 2022 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV) today announced its debut as an independent publicly traded company and the completion of its separation from Zimmer...